Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Gold Retest Coming

Gold and silver stocks have held up decently during the correction in precious metals, which is now in its 3rd month. However, as we mentioned last week, the bugaboo has been the relatively high net speculative position in Gold, which has not changed much despite recent weakne...
Jordan Roy-Byrne, CMT | November 12, 2019 |

Fission Uranium: As demand for clean energy grows, so too will the demand for uranium

Many countries across the world, including the United States and its new generation of modular reactors, are more and more looking towards nuclear solution to solve their clean energy problems and accelerate decarbonization. As nuclear energy grows, so too will the d...
Simon Druker | November 4, 2022 |

Analyst Upgrade Ignites Duchenne's Muscular Dystrophy Research Firm's Shares

Solid Biosciences' shares are up by more than 40% today after Chardan Capital Markets upgraded the firm's shares from "neutral" to "buy" and raised its price target from $7.50 to $10.00/share. Duchenne muscular dystrophy (DMD) research firm Solid Biosciences ...
Streetwise Reports | August 20, 2019 |

The Message From Common Stock Market Retracement Levels

RETRACEMENTS SPEAK TO ODDS If we are to believe the market’s rally off the December 2018 low is the last hurrah, we would expect to see some damage on the normal retracement front. Using the last rally into the S&P 500’s major October 2007 p...
Chris Ciovacco | October 8, 2019 |

Crude Oil Meets Key Resistance

Crude oil moved above the previous highs and at the moment of writing these words, it’s testing the upper border of the March price gap. And given the fundamental news that are reaching (and likely to reach) the market – the increasing Covid-19 cases in the U...
Nadia Simmons | June 23, 2020 |

Calibre Has Some Safety in the Storm

Last week provided a glimpse into the future of the stock market. Only a glimpse. It is going to get a whole lot worse. On January 1, I said in an article I titled Beware the Stock Market , " As the Everything Bubble pops, the financial system will destroy most inves...
Streetwise Reports | March 2, 2020 |

Royalties Inc.: the most fun, most lucrative investment you know and love, but never had the opportu

Royalties Inc. focuses on cash flow generating royalty opportunities across a wide variety of very different industries. Through its stake in Music Royalties Inc., the Toronto-based company provides direct exposure to music revenues from the recent hyper-growth in glo...
Simon Druker | April 25, 2023 |

Star Navigation Systems Group: What is an Inflight Safety Monitoring System and why is this tech uni

Star Navigation bridges the gap between flight experience and flight safety. In the aerospace industry, the Ontario-based aviation safety tech company offers both hardware and software solutions that work in real-time. The company continues to gain traction with ...
Simon Druker | March 14, 2023 |

GlucoTrack: Company Addresses the Diabetes Testing and Monitoring Conundrum

GlucoTrack ( NDAQ:GCTK ) is an American medical device company focused on design, development and commercialization. The company is developing proprietary painless and non-invasive blood glucose monitoring devices for both Type 2 diabetes and prediabetes, a market almost ...
Simon Druker | January 16, 2023 |

Mandalay Resources: A Canadian resource company with an international focus

Mandalay Resources is a Toronto-based natural resource company with an international focus. The precious metals explorer already has producing assets in Australia and Sweden. Its focus remains on furthering growth at both operations, reducing associated costs where it can...
Simon Druker | October 24, 2022 |
1 2 3 4 5 6 7 8 9 10 ...